Você procurou por: ornithine (Inglês - Esloveno)

ornithine
ornitin

l-ornithine
l-ornitin

ornithine not applicable
se ne uporablja

ornithine aspartate (innm)
ornitin aspartat (innm)

ornithine carbamoyltransferase deficiency;
pomanjkanje ornitin karbamoiltransferaze;

l-ornithine: 2,8 g
l-ornitin: 2,8 g

l-ornithine, n(5)-(aminocarbonyl)-
l-ornitin, n(5)-(aminokarbonil)-

activity), gamma glutamyl transpeptidase, ornithine decarboxylase,
gama-glutamil-transpeptidaza, ornitin-dekarboksilaza,

eflornithine blocks the action of an enzyme, ornithine decarboxylase.
eflornitin blokira delovanje encima ornitin dekarboksilaze.

the system must ensure that lysine is separated from ‘lysine artifacts’ and ornithine.
sistem mora zagotavljati, da se lizin loči od „lizinskih artefaktov“ in ornitina.

eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme involved in the production of the hair shaft by the hair follicle.
zdravilo vaniqa upo asni rast las.

the active substance in vaniqa, eflornithine, works by blocking the action of an enzyme called ornithine decarboxylase.
zdravilna učinkovina zdravila vaniqa, eflornitin, deluje tako, da zavira delovanje encima, imenovanega ornitin dekarboksilaza.

hyperargininaemia; ornithine translocase deficiency (hyperornithinaemia-hyperammonaemia homocitrullinuria (hhh) syndrome).
hiperargininemija; pomanjkanje ornitin translokaze (sindrom hiperornitinemija-hiperamonemija-homocitrulinurija (sindrom hhh)).

ammonaps is indicated as adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase.
zdravilo ammonaps uporabljamo kot dodatno zdravljenje pri dolgoročnem obravnavanju motenj ciklusa sečnine, ki vključujejo pomanjkljivosti karbamoilfosfat-sintaze, ornitin transkarbamoilaze ali argininosukcinat-sintaze.

, ornithine decarboxylase, gamma glutamyl transpeptidase, urea nitrogen, albumin, blood creatinine, total bilirubin and total serum protein measurements.
, ornitin-dekarboksilaze, gama-glutamil-transpeptidaze, sečnine, albumina, kreatinina v krvi, skupnega bilirubina in skupnih serumskih proteinov.

citrulline or arginine supplementation is required for patients diagnosed with neonatal-onset form of carbamyl phosphate synthetase or ornithine transcarbamylase deficiency at a dose of 0.17 g/ kg/ day or 3.8 g/ m2/ day.
za bolnike z diagnozo neonatalnega pojava pomanjkljivosti karbamoilfosfat- sintaze je potrebno dopolnjevanje prehrane s citrulinom v odmerku 0, 17 g/ kg/ dan oziroma pri pomanjkljivosti ornitin transkarbamoilaze pa je potrebno dopolnjevanje prehrane z argininom v odmerku 3, 8 g/ m2/ dan.